Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
ipo
3
×
life sciences
national blog main
boston
fda
national top stories
renaissance capital
san francisco
san francisco blog main
san francisco top stories
480 biomedical
antibiotics
arsenal medical
arvinas
astrazeneca
bob langer
boulder/denver
boulder/denver blog main
boulder/denver top stories
cancer
cancer drugs
carbapenem-resistant enterobacteriaceae
celgene
chronic rhinosinusitis
colorectal cancer
covid-19
deals
detroit
detroit blog main
detroit top stories
drug delivery
drugs
entasis therapeutics
genzyme
george whitesides
gritstone oncology
What
ipo
way
3
×
company
biotech
biotechs
cancer
cancer’s
chose
close
debut
developing
device
disease
firms
frontiers
ipos
known
late
life
lyra
make
maps
markets
medical
medicines
million
new
nose
noses
open
parlance
persistently
pharmaceutical
play
proteins
public
q
quarter
raised
raises
Language
unset
Current search:
ipo
×
way
×
@xconomy.com
3 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
